Go Pro

Jamieson Wellness (TSE:JWEL) Stock Rating Lowered by National Bank Financial

Jamieson Wellness logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • National Bank Financial downgraded Jamieson Wellness from “outperform” to “tender” and cut its price target from C$51.00 to C$45.75, implying only 0.44% upside.
  • Several other analysts also reduced their ratings to “hold” or equivalent; the stock has a consensus “Hold” rating and an average price target of C$46.54.
  • Shares were flat at C$45.55, near their 52-week high of C$45.76. The company reported quarterly EPS of C$0.46 on revenue of C$233.84 million.
  • MarketBeat previews top five stocks to own in September.

Jamieson Wellness (TSE:JWEL - Get Free Report) was downgraded by analysts at National Bank Financial from an "outperform" rating to a "tender" rating in a report issued on Monday,BayStreet.CA reports. They currently have a C$45.75 price objective on the stock, down from their previous price objective of C$51.00. National Bank Financial's price target points to a potential upside of 0.44% from the company's current price.

JWEL has been the topic of a number of other research reports. Canaccord Genuity Group cut shares of Jamieson Wellness from a "buy" rating to a "hold" rating and upped their target price for the company from C$44.50 to C$45.75 in a research note on Monday, August 10th. Stifel Nicolaus lowered Jamieson Wellness from a "buy" rating to a "hold" rating and upped their price objective for the company from C$45.00 to C$45.75 in a research note on Friday, August 7th. Canadian Imperial Bank of Commerce cut Jamieson Wellness from an "outperformer" rating to a "tender" rating and increased their target price for the stock from C$44.00 to C$45.75 in a report on Friday, August 7th. Royal Bank Of Canada downgraded Jamieson Wellness from an "outperform" rating to a "sector perform" rating and cut their target price for the stock from C$46.00 to C$45.75 in a research report on Monday, August 10th. Finally, TD lowered Jamieson Wellness from a "buy" rating to a "hold" rating and boosted their price target for the company from C$48.00 to C$49.00 in a research note on Monday, August 10th. One equities research analyst has rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Jamieson Wellness currently has a consensus rating of "Hold" and a consensus price target of C$46.54.

View Our Latest Research Report on Jamieson Wellness

Jamieson Wellness Stock Performance

JWEL stock remained flat at C$45.55 during midday trading on Monday. The company had a trading volume of 210,876 shares, compared to its average volume of 117,566. The firm has a market capitalization of C$1.89 billion, a price-to-earnings ratio of 24.89 and a beta of 1.48. Jamieson Wellness has a 52-week low of C$32.54 and a 52-week high of C$45.76. The stock's 50 day simple moving average is C$42.55 and its 200-day simple moving average is C$37.82. The company has a quick ratio of 1.08, a current ratio of 3.41 and a debt-to-equity ratio of 93.69.

Jamieson Wellness (TSE:JWEL - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported C$0.46 earnings per share (EPS) for the quarter. Jamieson Wellness had a net margin of 8.92% and a return on equity of 15.93%. The firm had revenue of C$233.84 million for the quarter. On average, equities analysts forecast that Jamieson Wellness will post 2.1438892 EPS for the current year.

About Jamieson Wellness

(Get Free Report)

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.

Featured Stories

Analyst Recommendations for Jamieson Wellness (TSE:JWEL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Jamieson Wellness Right Now?

Before you consider Jamieson Wellness, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.

While Jamieson Wellness currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines